Thiogenesis Therapeutics Corp.

  • Market Cap: N/A
  • Industry: Finance
  • ISIN: CA88410L1022
CAD
0.63
0.03 (5.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Thiogenesis Therapeutics Corp. stock-summary
stock-summary
Thiogenesis Therapeutics Corp.
Finance
Rozdil Capital Corp. is a Canada-based capital pool company. The principal business of the Company is the identification and evaluation of assets or businesses with the intention of completing a qualifying transaction under relevant policies of the exchange. It has not commenced any operations and has no assets.
Company Coordinates stock-summary
Company Details
4 King Street West, Ste. 401 , Toronto ON : M5H 1B6
stock-summary
Tel: 1 647 8467766
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summary
Industry

Finance

stock-summary
Market cap

CAD 31 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-509.41%

stock-summary
Price to Book

30.84